Targeting PDGFRa using PET Imaging to Diagnose Metastatic Papillary Thyroid Cancer and Improve Treatment

使用 PET 成像靶向 PDGFRa 诊断转移性甲状腺乳头状癌并改善治疗

• 批准号: 379019
• 负责人: McMullen Todd
• 金额: $ 7.29万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-10-01 至 2018-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=379019&lang=en
• 关键词: Cell Differentiation; Immuno-Pet-Pdgfra; Papillary Thyroid Cancer; Radiopharmaceutical

We have identified a marker of aggressive disease in papillary thyroid cancer that can be used as a means to find metastatic disease. Metastatic disease is common but often hard to find in thyroid cancer patients. We have created an imaging tool that can

我们已经确定了乳头状甲状腺癌侵袭性疾病的标志，可以用来作为发现转移性疾病的一种手段。转移性疾病很常见，但在甲状腺癌患者中往往很难发现。我们已经创建了一种成像工具，可以